Dr. LaVigne Mager is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.
Specializing In:Robotic surgery Cervical dysplasia and cervical lesions Fertility sparing treatment of gynecologic cancers
About Katherine LaVigne Mager
I was born and raised in New York City, where I attended college at Columbia University. I did my medical school training in Philadelphia at the Sidney Kimmel Medical College of Jefferson University (previously Jefferson Medical College) then returned to New York City for residency training at New York University Medical Center and fellowship training in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center. During my fellowship, my training covered all aspects of care of women with gynecologic malignancies with a focus on minimally invasive surgery, including robotic surgery and treatment of advanced and recurrent ovarian malignancies.
My areas of clinical interest include the treatment of gynecologic malignancies, consisting of cancers of the ovary, cervix, uterus, vulva, and vagina. I have a particular interest in surgical management, including fertility-sparing surgery for early-stage cancers. My research interests include better understanding the interplay between the immune system and gynecologic cancers, the treatment of cervical cancer, and improvements in surgical management of all gynecologic malignancies. I am also passionate about medical education and have won numerous awards for resident education as both a resident and a fellow. I am a member of the Society of Gynecologic Oncology.
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology
- Department of Gynecologic Oncology
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
- Clinical Assistant Professor
Education and Training:
- 2007-2011 - MD - Sidney Kimmel Medical College of Jefferson University, Philadelphia, PA
- 2011-2015 - New York University Medical Center, New York, NY
- 2015-2019 - Memorial Sloan Kettering Cancer Center, New York, NY
- Society of Gynecologic Oncology
Honors & Awards:
- 2017, 2018 - Society of Memorial Gynecologic Oncologists Virginia K. Pearce, MD Scholarship
- 2012-2015 - New York University Obstetrics and Gynecology Residency Program Senior Resident Teaching Award
- Alpha Omega Alpha Honor Medical Society
- Hobart Amory Hare Medical Honors Society of Jefferson Medical College
- Memorial Sloan Kettering Fellowship Award for Exemplary Teaching
Featured on Cancer Talk
Showing all3 of 4 CollapseView all
- Mager KL*, Jiménez-Sánchez A*, Cybulska P*, et al. Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy. Nat Genet 2020 (52): 582–593.
- Brandt B, Sioulas V, Basaran D, Kuhn T, LaVigne K, Gardner GJ, Sonoda Y, Chi DS, Long Roche KC, Mueller JJ, Jewell EL, Broach VA, Zivanovic O, Abu-Rustum NR, Leitao MM. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes. Gynecol Oncol. 2020;156(3):591-597.
- LaVigne K, Hyman DM, Zhou QC, Iasonos A, Tew, WP, Aghajanian C, Makker V, Hensley ML, Konner J, Grisham R, Cangemi N, Soldan K, Sabbatini PJ, Spriggs DR, O’Cearbhaill R. A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer. Int J Gynecol Cancer. 2018(28):1176-1182.
- LaVigne K, Seligman NS, Berghella V. Offering aneuploidy screening to HIV-positive women: routine counseling or not? BJOG. 2011 Jun;118(7):775-8
- Cibula D, Abu-Rustum NR, Fischerova D, Pather S, LaVigne K, Slama J, Alektiar K, Ming-Yin L, Kocian R, Germanova A, Fruhauf F, Dostalek L, Dusek L, Narayan K. Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy- A retrospective cohort study and review of the literature. Gynecol Oncol. 2018 (151): 438-443.
- Chan SW, LaVigne KA, Port ER, Fey JV, Brogi E, Borgen PI, Cody HS 3rd. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer? Annals of Surgical Oncology. 2008 Jan;247(1):143-9.